Largest Covid Vaccine Study Yet Finds Links to Health Conditions
Story by Jason Gale • Feb 19, 2024 Microsoft Start A healthcare worker administers a dose of the Novavax Covid-19 vaccine at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022. Novavax’s protein-based Covid-19 vaccine received long-sought US emergency-use authorization in July, but use is likely to be limited.© Bloomberg (Bloomberg) — Vaccines that protect against […]